She is an Associate Professor in Department of Sport, Rehabilitation and Dental Sciences at the Tshwane University of Technology in Pretoria, Gauteng, where she has been a faculty member since 1999. Yvonne has completed her PhD at the University of Pretoria which focuses on the discipline of Biokinetics and Sport Science, and her undergraduate was completed at University of Durban Westville in Kwa-Zulu Natal (Currently called University of Kwa-Zulu Natal). Her research interest lies in the area of Diabetes Mellitus and in particular the Efficacy of Exercise as a modality of treatment for Diabetes Mellitus. She works in research areas related to Diabetes Mellitus and uses exercise as the treatment modality as the core treatment. She has published numerous articles in the area pertaining to health and wellness She is also a registered Biokineticist, a profession that uses exercise as a core modality as a final phase rehabilitation. Yvonne is currently one of the Directors on the South African Biokinetics Board for National and International relations, she has served on national and international scientific committees, has chaired national and international conferences.
Dr. Yasir Zaroug is one of our highly qualified and best expert Family Practice / General Practice - Diabetes and Chronic Diseases Management with an invaluable experience of over 6 years. He is working as an expert Family Practice / General Practice in Yasir Mohammed Zaroug Elradi. He has completed FAMILY PHYSICIAN for his training and expertise. His residence is in as-Salimiyah, Hawalli, Kuwait. He fluently communicates with the patients in English, Arabic, French.
Type 2 diabetes mellitus (DM) is a growing worldwide epidemic with more than 422 million affected globally, with high incidence, and a prevalence rate of 10% in the Middle East and North Africa (MENA), particularly in Kuwait where prevalence rate is 15.8% and one third of Kuwaiti adults are affected. There are many comprehensive studies confirming the large benefit to glycemic control and reduction of diabetic complications rates when the chronic care model is implemented effectively for DM care.
Dr Gihane Khalil Professor of Chemical Pathology. Medical Research Institute. Alexandria University, Egypt. I am very interested in the field of diabetes management. I have many publications in the field of diabetes, obesity, insulin resistance as well as breast cancer research. I supervised many thesis concerned with diabetes and obesity.
Diabetes mellitus (DM) is a powerful and independent risk factor for cardiovascular disease. The atherosclerosis process in diabetes is indistinguishable from that of the non-diabetic population, but it begins earlier and is often more extensive and more severe. AIF-1 promotes chemo taxis, spreading and migration of macrophages and vascular smooth muscle cells (VSMCs) which suggest a role of AIF-1 in the atherosclerotic plaque formation. Thus, This study determines the role of AIF-1 In the Egyptian Type 2 Diabetic Patients with Atherosclerosis. The level of AIF-1 was significantly higher in the diabetic atherosclerotic groups when compared to the control group (p=0.000). In diabetic atherosclerotic patients group, there was a significant positive correlation between CIMT and AIF-1 (r=0.468,Â p= 0.000) , denoting the possible role of elevated serum AIF-1 levelÂ in atherosclerotic process. Thus, AIF-1 could be used as a marker ofÂ atherosclerosis in diabetic patients.
Dr. Hamzeh Awad has completed his PhD at the age of 30 from the University of Munich, Germany and worked in Healthcare Operation and System, Planning and Development, Disability, Rehabilitation, Diabetes and eHealth in different countries such as Germany, Belgium, Jordan, Saudi Arabia, UK and UAE. Further; he was appointed as a Researcher at WHO center in Munich, Researcher at University Hospital of Technical University of Dresden, Assistant Prof. at King Saud University in Riyadh, and Research and Clinical programs Development Manager at Prince Sultan Rehabilitation City, KSA. Dr. Awad, was appointed as “Associate Professor” in Health Science Department at Al Khawarizmi International College (KIC) in Abu Dhabi and Adjunct Faculty member in Public Health Department, Abu Dhabi University, UAE and Senior eHealth consultant at e-Point, Belgium (Founder of SEHA eHealth). Recently, Dr. Awad, started his new role in academia at Higher College of Technology (HCT) teaching Health Information Management (HIM), UAE. He has several publications in ISI journals and chapters in Books and keynote speaker in several international conferences. He has several international collaborations with different research groups in Healthcare system, Physical therapy and Rehabilitation, Diabetes, Health Information Technology, Health Management and eHealth.
The “Comprehensive ICF Core Set for Diabetes Mellitus“ is an application of the International Classification of Functioning, Disability and Health (ICF) and represents the typical spectrum of problems in functioning in patients with diabetes mellitus (DM). The International Classification of Functioning, Disability and Health (ICF) is a framework for describing and organizing information on functioning and disability. It provides a standard language and a conceptual basis for the definition and measurement of health and disability.The aim of this study is to present a call to action framework using validated ICF Core Set for DM from the perspectives of physical therapists (PT) in Health Information System (HIS). Twenty-two PTs, from 11 countries, answered 1st round, 23 PTs completed the second and third Delphi rounds. PTs reached consensus on 49 ICF categories. 36/49 (73%) ICF categories are represented in the ICF Core Set for DM, while 13/49 (27%) categories are not represented in the ICF Core Set for DM. 5 concepts were linked to the ICF component of Personal Factors, which is not yet classified into detailed categories. The validity of the ICF Core Set for DM from the perspective of PTs was supported. The ICF appears to provide an effective framework for PTs in the field of DM. Therefore, it is worth using such framework in HIS and apply it in clinical practice (fig1 & 2).
The author received an honourable PhD in mathematics and majored in engineering at MIT. He attended different universities over 17 years and studied seven academic disciplines.He has spent 20,000 hours in T2D research. First, he studied six metabolic diseases and food nutrition during 2010 to 2013, then conducted his own diabetes research during 2014 to 2018. His approach is “quantitative medicine” based on mathematics, physics, optical and electronics physics, engineering modelling, signal processing, computer science, big data analytics, statistics, machine learning, and artificial intelligence. His main focus is on preventive medicine using prediction tools. He believes that the better the prediction, the more control you have.
Introduction: This paper discusses glucose measurement results from two different methods, finger piercing and testing strip (Finger) and Libre’s continuous glucose monitoring system (Sensor). Method: The author has been collecting a total of 9,490 glucose data by finger measurement, including both fasting plasma glucose (FPG) once a day since 1/1/2014 (1,825 days) and postprandial plasma glucose (PPG) three times a day since 1/1/2012 (2,555 days). Recently, he has further collected 17,046 glucose data by applying a sensor on his upper arm to collect his glucose values continuously. This sensor measurement is conducted in parallel with his routine finger measurements. During the period of 5/5/2018 to 12/31/2018 (241 days), he has recorded his sensor glucose values about 71 times per day. The measurement rate is approximately every 15 minutes during the day and every hour during the night. In summary, he has collected a total of 964 waveforms - 241 FPG and 723 PPG. Other waveforms generated between meals or from eating snack/fruit are not included in this analysis.